PersonalBy blending the sponsor's trial insights with our focus, coordination, and local intelligence, we make each day count from start-up to data lock.
GlobalAs a truly transnational organization, AmeRuss provides sponsors the advantages of trial recruitment from the best of Eastern Europe.
SwiftTime is of the essence and integral to the bottom line. While protecting the trial's integrity, we work to create and maintain accelerated project timelines.
SolutionsFind your perfect balance of sites and investigators in Russia and the CIS combined with customized services specific to your product and trial.
Ready to Have your Expectations Exceeded?
Paul Caldron President and CEOPaul Caldron, DO, FACP, FACR, MBAPaul Caldron, DO, FACP, FACR, is a United States trained physician certified in internal medicine, rheumatology and geriatric medicine and is former CEO of the...more
Pavel Shafranovskiy Vice President, Corporate DevelopmentPavel Shafranovskiy, PhD, MBAPavel Shafranovskiy, PhD, MBA holds a doctorate in chemical physics in Russia and business master’s from the Open University of the United Kingdom, and is...more
Andrei Bazarov Medical Director, Country Manager Russia/CISAndrei Bazarov, MDAndrei Bazarov, MD is Medical Director for AmeRuss and Acting Country Manager overseeing Russia, Belarus, and Ukraine. Dr. Bazarov holds a medical degree in Surgery...more
Personal Attention with Multinational Benefits
AmeRuss Clinical Trials, LLC is a Contract Research Organization (CRO) with corporate offices in the United States and investigative offices in Russia and former Soviet Union regions (Ukraine, Belarus, Kazakhstan, Moldova, Armenia, Georgia, Azerbaijan). AmeRuss is uniquely positioned to support pharmaceutical and medical device companies in fast-tracking their products to market. AmeRuss’s nimble and time efficient approach to clinical research provides the sponsor with trial performance that meets or exceeds what the world has learned to expect from this clinical trial “superpower” region. AmeRuss’s managing partners include three physician investigators who together have completed more than 450 clinical trials. As a sponsor, you can expect quality work and personal attention without undue administrative delays commonplace during trial conduction.more
Reach investigators and subjects in Russia and the CIS with low exposure to modern research.
Our CRAs, in regional office from Moscow to Yakutsk, and leaders’ relationships with regulatory authorities ensure swift local and national study approvals and initiation.
A Phase 2, Open-Label, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability...Full Article
AmeRuss is launching a phase III multinational study in prepubertal children with growth hormone deficiency...Full Article
Medical Device clinical study in treatment of uncontrolled hypertension – an international program launch AmeRuss...Full Article